{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:09:19Z","timestamp":1791896959215,"version":"4.3.4"},"reference-count":35,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.3201\/eid2706.203206","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T13:03:02Z","timestamp":1621429382000},"page":"1588-1597","source":"Crossref","is-referenced-by-count":56,"title":["Macrolide-Resistant <i>Mycoplasma pneumoniae<\/i> Infections in Children, Ohio, USA"],"prefix":"10.3201","volume":"27","author":[{"given":"Mariana M.","family":"Lanata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Moore-Clingenpeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Leber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2706.203206-202105162156-R1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen.","volume":"17","author":"Waites","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2706.203206-202105162156-R2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children.","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2706.203206-202105162156-R3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond.","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid2706.203206-202105162156-R4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fmicb.2016.00157","article-title":"Mycoplasma pneumoniae epidemiology in England and Wales: a national perspective.","volume":"7","author":"Brown","year":"2016","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R5","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2706.203206-202105162156-R6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment.","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R7","doi-asserted-by":"publisher","first-page":"ofv106","DOI":"10.1093\/ofid\/ofv106","article-title":"molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States.","volume":"2","author":"Diaz","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid2706.203206-202105162156-R8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-resistant Mycoplasma pneumoniae, United States.","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2706.203206-202105162156-R9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.02597-14","article-title":"Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013.","volume":"53","author":"Diaz","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R10","doi-asserted-by":"publisher","first-page":"e00968-19","DOI":"10.1128\/JCM.00968-19","article-title":"Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program.","volume":"57","author":"Waites","year":"2019","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2706.203206-202105162156-R12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/AAC.04308-14","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R13","doi-asserted-by":"publisher","first-page":"e00710-20","DOI":"10.1128\/JCM.00710-20","article-title":"molecular characterization of Mycoplasma pneumoniae isolates in the United States from 2012 to 2018.","volume":"58","author":"Xiao","year":"2020","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R14","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","article-title":"Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.","volume":"48","author":"Matsuoka","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.","volume":"6","author":"B\u00e9b\u00e9ar","year":"2011","journal-title":"Future Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children.","volume":"51","author":"Cardinale","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R19","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R20","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","article-title":"Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia.","volume":"26","author":"Chen","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2706.203206-202105162156-R21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-7012(00)00135-4","article-title":"Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR.","volume":"41","author":"Hardegger","year":"2000","journal-title":"J Microbiol Methods"},{"key":"key-10.3201\/eid2706.203206-202105162156-R22","doi-asserted-by":"crossref","unstructured":"Leber AL, editor. Clinical Microbiology Procedures Handbook, 4th ed. Washington (DC): ASM Press; 2016.","DOI":"10.1128\/9781555818814"},{"key":"key-10.3201\/eid2706.203206-202105162156-R23","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1128\/AAC.00582-08","article-title":"Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.","volume":"52","author":"Wolff","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R24","unstructured":"Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing for human mycoplasmas (M43-Al). Annapolis Junction (MD): The Institute; 2011."},{"key":"key-10.3201\/eid2706.203206-202105162156-R25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","article-title":"Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children.","volume":"60","author":"Lee","year":"2017","journal-title":"Korean J Pediatr"},{"key":"key-10.3201\/eid2706.203206-202105162156-R26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jiac.2020.10.007","article-title":"Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.","volume":"27","author":"Nakamura","year":"2021","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s10156-012-0523-3","article-title":"Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.","volume":"19","author":"Wu","year":"2013","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.","volume":"15","author":"Matsubara","year":"2009","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2706.203206-202105162156-R29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jmii.2014.11.003","article-title":"Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.","volume":"49","author":"Cheong","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.3201\/eid2706.203206-202105162156-R30","first-page":"629","article-title":"Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"20","author":"Chen","year":"2018","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"key-10.3201\/eid2706.203206-202105162156-R31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ppul.22851","article-title":"Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.","volume":"49","author":"Ma","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"key-10.3201\/eid2706.203206-202105162156-R32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","article-title":"Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.","volume":"17","author":"Kawai","year":"2012","journal-title":"Respirology"},{"key":"key-10.3201\/eid2706.203206-202105162156-R33","doi-asserted-by":"publisher","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2706.203206-202105162156-R34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3346\/jkms.2017.32.10.1642","article-title":"Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae from children in Jeju.","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"key-10.3201\/eid2706.203206-202105162156-R35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fcimb.2020.00385","article-title":"Periodic genotype shifts in clinically prevalent Mycoplasma pneumoniae strains in Japan.","volume":"10","author":"Kenri","year":"2020","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-3206_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:52:05Z","timestamp":1732989125000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/6\/20-3206_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2706.203206","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}